Carcinogenesis

Papers
(The TQCC of Carcinogenesis is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Editor-In-Chief’s Editorial 202362
Intermittent administration of tacrolimus enhances 
anti-tumor immunity in melanoma-bearing mice41
Genomic profile of radiation-induced early-onset mouse B-cell lymphoma recapitulates features of Philadelphia chromosome-like acute lymphoblastic leukemia in humans39
Identification of biomarkers for the diagnosis and targets for therapy in patients with clear cell ovarian cancer: a systematic literature review33
The putative oncogenic role of WDTC1 in colorectal cancer31
LINC02418 upregulates EPHA2 by competitively sponging miR-372-3p to promote 5-Fu/DDP chemoresistance in colorectal cancer28
miR-1304 targets KLK11 to regulate gastric cancer cell proliferation through the mTOR signaling pathway27
Unravelling the distinct biological functions and potential therapeutic applications of TIMP2 in cancer27
O-GlcNAcylation of RAB10 promotes hepatocellular carcinoma progression26
The environmental carcinogen benzo[a]pyrene regulates epigenetic reprogramming and metabolic rewiring in a two-stage mouse skin carcinogenesis model26
Regulatory mechanisms of PFKFB2 in glycolysis and tumor metabolism: implications for cancer therapy26
Identification of HCAR1 as a ferroptosis-related biomarker of gastric cancer based on a novel ferroptosis-related prognostic model and in vitro experiments25
Cancer-testis non-coding RNA LEF1-AS1 regulates the nuclear translocation of PDCD5 and suppresses its interaction with p53 signaling: a novel target for immunotherapy in esophageal squamous cell carci25
Prognostic value of circulating tumor DNA in different cancer types detected by ultra-low-pass whole-genome sequencing: a systematic review and patient-level survival data meta-analysis24
miR-22 promotes immunosuppression via activating JAK/STAT3 signaling in cutaneous squamous cell carcinoma24
Correction to: Triple-negative breast cancer molecular subtypes and potential detection targets for biological therapy indications24
Longitudinal single-cell RNA model aids prediction of EGFR-TKI resistance24
Redefining pancreatic cancer management with tumor-agnostic precision medicine22
LncRNA LINC02253 activates KRT18/MAPK/ERK pathway by mediating N6-methyladenosine modification of KRT18 mRNA in gastric cancer22
Ehm2 transcript variant 1 inhibits breast cancer progression and increases E-cadherin stability21
Editor-in-Chief’s Note—Thank you to Reviewers20
Epidemiological evidence for associations between variants in microRNA and cancer risk19
Association between new plasma inflammatory markers and risk of colorectal neoplasms in individuals over 50 years old19
Intratumoral vitamin D signaling and lethal prostate cancer19
Long non-coding RNA NRAV in the 12q24.31 risk locus drives gastric cancer development through glucose metabolism reprogramming18
Solamargine enhanced gefitinib antitumor effect via regulating MALAT1/miR-141-3p/Sp1/IGFBP1 signaling pathway in non-small cell lung cancer17
Long noncoding RNA XIST: a novel independent prognostic biomarker for patients with ABC-DLBCL receiving R-CHOP treatment17
Human cytomegalovirus alters immune cell profile with potential implications for patient survival in head and neck cancer17
SIAH1/CTR9 axis promotes the epithelial–mesenchymal transition of hepatocellular carcinoma16
α5-nAChR/STAT3/CD47 axis contributed to nicotine-related lung adenocarcinoma progression and immune escape16
LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism16
Machine learning based on biological context facilitates the identification of microvascular invasion in intrahepatic cholangiocarcinoma15
Urinary glyphosate levels and association with mortality in the 2013–16 National Health and Nutrition Examination Survey15
Antibody–drug conjugates in breast cancer15
Establishing a new-onset diabetes-related metabolism signature for predicting the prognosis and immune landscape in pancreatic cancer15
miR-3154 promotes hepatocellular carcinoma progression via suppressing HNF4α15
DUT enhances drug resistance to proteasome inhibitors via promoting mitochondrial function in multiple myeloma14
MPZL1 upregulation promotes tumor metastasis and correlates with unfavorable prognosis in non-small cell lung cancer14
ITGA2 as a prognostic factor of glioma promotes GSCs invasion and EMT by activating STAT3 phosphorylation13
Endometrial hyperplasia with loss of APC in a novel population of Lyz2-expressing mouse endometrial epithelial cells13
PPM1G promotes the progression of lung adenocarcinoma by inhibiting p38 activation via dephosphorylation of MEK613
Copine 1 predicts poor clinical outcomes by promoting M2 macrophage activation in ovarian cancer13
Prognostic value of exosomal noncoding RNA in hepatocellular carcinoma: a meta-analysis13
The impact of reproductive factors on breast tumor and normal-adjacent tissue immune profile from menarche to menopause13
SRSF3 knockdown-induced cellular senescence as a possible therapeutic strategy for non-small cell lung cancer13
SLC38A6, regulated by EP300-mediated modifications of H3K27ac, promotes cell proliferation, glutamine metabolism and mitochondrial respiration in hepatocellular carcinoma13
Germline alteration analysis reveals EPHB4R91H mutation as a key player in multiple primary lung tumors13
From precursor to cancer: decoding the intrinsic and extrinsic pathways of pancreatic intraepithelial neoplasia progression12
Genetic variants in glycosylation pathways are associated with colorectal cancer risk12
Immune-related genes for the prediction of response to imatinib therapy in chronic myeloid leukemia12
Outcome of clinical experience of introducing a patient with secondary systemic AL-amyloidosis associated with multiple myeloma12
CYR61 confers chemoresistance by upregulating survivin expression in triple-negative breast cancer12
MALAT1 regulates network of microRNA-15a/16–VEGFA to promote tumorigenesis and angiogenesis in multiple myeloma12
BRAF V600E-induced distinct DNA damage response defines the therapeutic potential of p53 activation for TP53 wild-type colorectal cancer12
SSH1 promotes progression of intrahepatic cholangiocarcinoma via p38 MAPK-CXCL8 axis11
CacyBP promotes the development of lung adenocarcinoma by regulating OTUD511
SMARCA4/BRG1 deficiency induces a targetable dependence on oxidative phosphorylation in clear cell renal cell carcinoma11
Sevoflurane inhibits lung cancer development by promoting FUS1 transcription via downregulating IRF611
Actinomycin D synergizes with Doxorubicin in triple-negative breast cancer by inducing P53-dependent cell apoptosis11
Elevated expression of the membrane-anchored serine protease TMPRSS11E in NSCLC progression11
MAPK3 modulates enhancer–promoter interactions of SKAP2 in acute myeloid leukemia11
AKT/GSK-3beta/VEGF signaling is involved in P2RY2 activation-induced the proliferation and metastasis of gastric cancer11
LncRNA-encoded peptide LRRC75A-AS1-ORF3 suppresses anti-tumor immunity in colorectal cancer through mitophagy-mediated attenuation of cGAS-STING signaling11
Cancer-associated fibroblasts promote cancer stemness by inducing expression of the chromatin-modifying protein CBX4 in squamous cell carcinoma10
Copper in colorectal cancer patients: a systematic review and meta-analysis10
m6A-modified circASXL1 promotes proliferation and migration of ovarian cancer through the miR-320d/RACGAP1 axis10
Suppressing the activation of protein kinase A as a DNA damage-independent mechanistic lead for dihydromethysticin prophylaxis of NNK-induced lung carcinogenesis10
Somatic p53 mutations that are markedly overrepresented in lung cancer confer resistance to reactive oxygen species-induced cell death10
E3 ubiquitin ligase RNF148 functions as an oncogene in colorectal cancer by ubiquitination-mediated degradation of CHAC210
Macrophage migration inhibitory factor as a prognostic biomarker in multiple myeloma: clinical significance and in vitro effects10
Comparison of radiation-related cancer risks from the atomic bomb survivors with studies of pediatric medical radiation exposure10
Dietary phytoestrogen intake and ovarian cancer risk: a prospective study in the prostate, lung, colorectal and ovarian (PLCO) cohort10
LncRNA CCAT1 participates in pancreatic ductal adenocarcinoma progression by forming a positive feedback loop with c-Myc10
Correction to: p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis10
Expression profile of Claudins 3, 4, and 7 in breast tumors and its correlation with clinicopathological features10
A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs10
LncRNAs act as modulators of macrophages within the tumor microenvironment9
Pan-cancer analysis of G6PD carcinogenesis in human tumors9
Stem cells, Notch-1 signaling, and oxidative stress: a hellish trio in cancer development and progression within the airways. Is there a role for natural compounds?9
NamiRNA-enhancer network of miR-492 activates the NR2C1-TGF-β/Smad3 pathway to promote epithelial-mesenchymal transition of pancreatic cancer9
Tumor-associated astrocytes inhibit tumor cell apoptosis through TNF-α–TNF receptor 2–NF-κB pathway in lung cancer brain metastasis9
ALDH2 dysfunction and alcohol cooperate in cancer stem cell enrichment9
The influence of homologous recombination repair on temozolomide chemosensitivity in gliomas8
Triple-negative breast cancer molecular subtypes and potential detection targets for biological therapy indications8
Bipolar high-frequency electric welding in radical resection of frontal sinus tumors8
Editor-In-Chief’s Editorial 2022 January Issue 43:18
Overview and future studies of potential hereditary effects of parental exposure to atomic bomb radiation on their offspring8
Adverse events and recent advances in CAR-T-cell therapy8
CCL18 promotes migration and invasion of multiple myeloma cells and is associated with poor prognosis8
Hepatitis B virus X protein promotes hepatocarcinogenesis via the activation of HMGA2/STC2 signaling to counteract oxidative stress-induced cell death8
Olfactomedin 4 promotes gastric cancer cell G2/M progression and serves as a therapeutic target in gastric adenocarcinoma8
Integrative analysis of enrichment and prognostic value of ferroptosis-related genes and pathways in multiple myeloma8
Chemopreventive efficacy of silibinin against basal cell carcinoma growth and progression in UVB-irradiated Ptch+/– mice8
Thymoquinone inhibits lung cancer stem cell properties via triggering YAP degradation8
Associations of prediagnostic serum liver enzyme levels with lung cancer risk in predominantly low-income African and European Americans8
Targeted sequencing and functional interrogation identified novel variant at 12q14.2 associated with risk of ovarian cancer in Han Chinese women8
BRINP3 promotes lung adenocarcinoma by enhancing CLOCK-mediated transcriptional regulation of CRYZL1 and activating the AKT pathway8
0.089807987213135